华恒生物：2025年营收增32.50%，净利润降30.97%

Core Viewpoint - The company expects to achieve a revenue of 2.886 billion yuan in 2025, representing a year-on-year increase of 32.50%, while net profit attributable to shareholders is projected to decrease by 30.97% to 131 million yuan [1] Financial Performance - Revenue is expected to increase due to higher sales of amino acid products [1] - Net profit is anticipated to decline due to falling product prices and rising expenses [1] - The company forecasts total assets of 5.779 billion yuan at the end of 2025, a year-on-year growth of 15.82% [1] - Shareholders' equity is projected to reach 2.645 billion yuan, reflecting a year-on-year increase of 3.14% [1] - Earnings per share is expected to be 10.58 yuan, up 3.02% year-on-year [1]